Genetic counseling for fragile X syndrome: Recommendations of the National Society of Genetic Counselors

Journal of Genetic Counseling

Volumn 9, Issue 4, 2000, Pages 303-325

  McIntosh, Nathalie ^a   Gane, Louise W ^b   McConkie Rosell, Allyn ^c   Bennett, Robin L ^d,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Treatment and Research Center   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Fragile X syndrome; Genetic counseling; Genetic testing; National Society of Genetic Counselors; Practice guidelines; Prenatal diagnosis

Indexed keywords

FRAGILE X SYNDROME; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; REVIEW;

EID: 0033912103     PISSN: 10597700     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009454112907     Document Type: Review

References (98)

1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Beechi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Vieri F (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study - Preliminary data. Am J Med Genet 83:322-325.
2. American College of Medical Genetics (1994) American College of Medical Genetics Policy Statement. Fragile X syndrome: Diagnostic and carrier testing. Am J Med Genet 53:380-381.
3. ASHG/ACMG Report (1995) Points to consider: Ethical, legal, and psychological implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241.
4. Ashley AE, Sherman SL (1995) Population dynamics of a meiotic/mitotic expansion model for the fragile X syndrome. Am J Hum Genet 57:1414-1425.
5. Ashley CT, Sutcliffe JS, Kunst CB (1993) Human and murine FMR-1: Alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 4:244-251.
6. Bell MV, Hirst MC, Nakahori Y, Mackinnon RN, Roche A, Flint TJ, Jacobs PA, Tommerup N, Tranebjaerg L, Froster-Iskenius U, Kerr B, Turner G, Lindenbaum RH, Winter R, Pembrey M, Thibodeau S, Davies KE (1991) Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome. Cell 64:861-866.
7. Bennett RL, Steinhaus KA, Uhrich SA, O'Sullivan CK, Resta RG, Lochner-Doyle D, Markel DS, Vincent V, Hamanishi J (1995) Recommendations for standardized pedigree nomenclature. Am J Hum Genet 56:745-752.
8. Black SH, Levinson G, Harton GL, Palmer FT, Sisson ME, Schoener C, Nance E, Fugger EF, Fields RA (1995) Preimplantation genetic testing (PGT) for fragile X (fraX). Am J Hum Genet 57:(Abstract 153)
9. Bridge PJ, Dimnik LS, Chernos JE, Wages J, Block W, McLeod DR (1999) Transmission of a fragile X full mutation from a premutation male to his two daughters. Genet Med 1:49:A23.
10. Brown CA, Brasington CK, Grass FS (1995) Paternal transmission of a full mutation in the FMR1 gene: Identification of paternal CGG repeat sizes in multiple tissues. Am J Hum Genet 57:A1947.
11. Brown WT, Houck GE, Ding X, Zhong N, Nolin S, Glicksman A, Dobkin C, Jenkins EC (1996) Reverse mutations in the fragile X syndrome. Am J Med Genet 64:287-292.
12. Brown WT, Houck Jr. GE, Jeziorowska A, Jeziorowka A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC (1993) Rapid fragile X carrier screening and prenatal diagnosis using nonradioactive PCR test. JAMA 270:1569-1575.
13. Cantu JM, Diaz-Gallardo MY, Barros-Nunez P, Figuera LE (1998) Heteroallelic monozygotic twins and triplets. Am J Med Genet 77:166-167 (letter to editor).
14. Chakravarti A (1992) Fragile X founder effect? Nat Genet 1:237.
15. Chong SS, Eichler EE, Nelson DL, Hughes MR (1994) Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am J Med Genet 51:522-526.
16. Clarke A (ed) (1998) The Genetic Testing of Children. Oxford: BIOS Scientific.
17. Clarke A, Flinter F (1996) The genetic testing of children: a clinical perspective. In: Marteau T, Richards M (eds), The Troubled Helix: Social and Pyschological Implications of the New Human Genetics. New York: Cambridge Univeristy Press, pp. 164-176.
18. De Boulle K, Verkerk AJMH, Reyniers E, Vits L, Dendrickx J, Van Roy B, Ban Den Bos F, de Graaff E, Oostra BA, Willems PJ (1993) A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3:31-35.
19. Decker-Phillips M, Parks LR, Longshore J, Crawford E, Tarleton J, McConkie-Rosell A (1996) Methylation studies of FMR1 in paired fetal and chorionic villus samples: Implications for prenatal diagnosis of fragile X syndrome using CVS. Am J Hum Genet 59:A205.
20. de Graaff E, Willemsen R, Zhong N, de Die-Smulders CE, Brown WT, Freling G, Oostra B (1995) Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet 3:609-618.
21. De Vries BBA, Halley DJJ, Oostra BA, Niermeijer MF (1998) The fragile X syndrome. J Med Genet 35:579-589.
22. De Vries BBA, Van den Ouweland AM, Mohkamsing S, Duivenvoorden HJ, Mol E, Gelsema K, VanRijn M, Halley DJ, Sandkuijl LA, Oostra BA, Tibben A, Niermeijer MF (1997) Screening and diagnosis for the fragile X syndrome among the mentally retarded: An epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet 61:660-667.
23. De Vries BBA, Wiegers AM, Smits APT, Mohkamsing S, Duivenvoorde JH, Fryns JP, Curfs LMG, Halleey DJJ, Oostra BA, van Den Ouweland AMW, Niermeijer MF (1996) Mental status of females with an FMR-1 gene full mutation. Am J Hum Genet 58:1025-1032.
24. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
25. Eichler EE, Holden J, Popovich BW, Reiss AL, Snow K, Thibodeau SN, Richards CS, Ward PA, Nelson DL (1994) Length of uninterrupted CGG repeats determines instability in the FMR-1 gene. Nat Genet 8:88-94.
26. Feng Y, Shang F, Lokey LK, Chastian JL, Lakkis L, Eberhart D, Warren ST (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734.
27. Finucane B (1998a) Acculturation in women with mental retardation and its impact on genetic counseling. J Genet Couns 7:31-47.
28. Finucane B (1998b) Working with Women Who Have Mental Retardation: A Genetic Counselor's Guide. Elwyn, Inc./The Jane Engelberg Memorial Fellowship.
29. Fisch GS, Snow K, Thibodeau SN, Chalifaux M, Holden JJA, Nelson DL, Howard-Peebles PH, Maddalena A (1995) The fragile X premutaiton in carriers and its effect on mutation size in offspring. Am J Hum Genet 56:1147-1155.
30. Franke P, Maier W, Iwers B, Hautzinger M, Froster UG (1996) Fragile X carrier females: evidence for a distinct psychopathological phenotype? Am J Med Genet 64:334-339.
31. Fu Y-H, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJMH, Holden JJA, Fenwick RG, Warren ST, Oostra BA, Nelson DL, Caskey CT (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
32. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC (1992) Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet 1:341-344.
33. Gibson TJ, Rice PM, Thompson JD, and Heringa J (1993) KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism. Trends Biochem Sci 18:331-333.
34. Hagerman RJ (1987) Fragile X Syndrome. Curr Probl Pediatr 17:621-674.
35. Hagerman RJ (1996) Physical and behavioral phenotype. In: Hagerman RJ, Silverman AC (eds) Fragile X Syndrome: Diagnosis, Treatment, and Research, 2nd ed, Baltimore: Johns Hopkins University Press.
36. Hagerman RJ, Cronister A (eds) (1996) Fragile X Syndrome, Diagnosis, Treatment, and Research, 2nd ed, Baltimore: Johns Hopkins University Press.
37. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, Oconnor RA, Seydel C, Mazzocco M, Snow K, Thibodeau SN, Kuhl D, Nelson DL, Caskey CT, Taylor AK (1994) High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298-308.
38. Hagerman RJ, Staley LW, O'Connor R, Lugenbeel K, Nelson D, McLean S, Taylor A (1996) Learning disabled males with fragile X CGG expansions in the upper premutation size range. Pediatrics 97:8-12.
39. Hamel BCJ, Smits APT, de Graaff E, Smeets DFCM, Scheute F, Eussen BHJ, Knight SJL, Davies KE, Assman-Hulsmans CGCH, Oostra BA (1994) Segregation of FRAXE in a large family: Clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet 55:923-931.
40. Heitz D, Rousseau F, Devys D, Saccone S, Abderrahim H, Le Paslier D, Cohen D, Vinent A, Toniolo D, Deel Valle G, Hohnson S, Schlessinger D, Oberle I, Mandel J-L (1991) Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science 251:1236-1239.
41. Helderman-van den Enden ATJM, Maaswinkel-Mooij PD, Hoogendoorn E, Willemsen R, Maat-Kievit JA, Losekoot M, Oostra BA (1999) Monozygotic twin brothers with the fragile X syndrome: different CGG repeats and different mental capacities. J Med Genet 36:253-357.
42. Khandjian EW, Corbin F, Woerly S, Rousseau F (1996) The fragile X mental retardation protein is associated with ribosomes. Nat Genet 12:91-93.
43. Kolehmainen K (1994) Population genetics of fragile X: A multiple allele model with variable risk of CGG repeat expansion. Am J Med Genet 51:428-435.
44. Kremer EJ, PritchardM, Lynch M, Yu S, Holman K, Baker E, Warrern ST, Schlessinger D, Cutherland GR, Richards RI (1991) Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714.
45. Kunst CB, Warren ST (1994) Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 77:853-861.
46. Lachiewicz AM, Spiridigliozzi GA, McConkie-Rosell A, Burgess D, Tarleton J (1996) A fragile X male with a broad smear on Southern blot of 100 to 500 CGG repeats and no methylation. Am J Med Genet 64:278-282.
47. Levinson G, Maddalena A, Palmer FT, Harton GL, et al. (1994) Improving sizing of fragile X CCG repeats by nested polymerase chain reaction. Am J Med Genet 51:527-534.
48. Loehr JP, Synhorst DP, Wolfe RR, Hagerman RJ (1986) Aortic root dilatation and mitral valve prolapse in fragile X syndrome. Am J Med Genet 23:189-194.
49. Macpherson J, Murray A, Webb J, Jacobs P (1999). Fragile X syndrome: of POF and premutations. J Med Genet 36:171.
50. Malter HE, Iber JC, Willemsen R, de Graaff E, Tarleton JC, Leisti J, Warren ST, Oostra BA (1997) Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet 15:165-169.
51. Marymee K, Dolan CR, Pagon RA, Bennett RL, Coe S, Fisher NL (1998) Development of critical elements of genetic evaluation and genetic counseling for genetic professionals and perinatologists in Washington State. J Genet Couns 7:133-165.
52. McConkie-Rosell A, Lachiewicz AM, Spiridigliozzi GA, Tarleton J, Schoenwald S, Phelan MC, Goonewardena P, Ding X, Brown WT (1993) Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet 53:800-809.
53. McConkie-Rosell A, Spiridigliozzi GA, Iafolla T, Tarleton J, Lachiewicz AM (1997) Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. Am J Med Genet 68:62-69.
54. McLeod DR, Bridge P, Chernos J (1999) Expansion of fragile X mutation from a normal transmitting male to full mutation in affected daughters. Proc Greenwood Genet Cent 18:176.
55. Meadows KL, Pettay D, Newman J, Hersey J, Ashley AE, Sherman SL (1996) Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population. Am J Med Genet 64:428-433.
56. Merenstein SA, Sobesky WE, Taylor AK, Riddle JE, Tran HX, Hagerman RJ (1996) Fragile X syndrome in normal IQ males with learning and behavioral problems: Molecular-clinical correlations in males with an expanded FMR-1 mutation. Am J Med Genet 64:388-394.
57. Michie S (1996) Predictive genetic testing in children: paternalism or empiricisms? In: Marteau T, Richards M (eds.) The Troubled Helix: Social and Psychological Implications of the New Human Genetics. New York: Cambridge University Press, pp. 177-183.
58. Morton JE, Bundey S, Webb TP, MacDonald F, Rindl PM, Bullock S (1997) Fragile X syndrome is less common than previously estimated. J Med Genet 34:1-5.
59. Morton NE, Macpherson JN (1992) Population genetics of the fragile X syndrome: Multiallelic model for the FMR1 locus. PNAS USA 89:4215-4217.
60. Mulley JC, Yu S, Loesch DZ, Hay DA, Donnelly A, Gedeon AK, Carbonell P, Lopez I, Glover G, Gabarron I, Yu PWL, Baker E, Haan EA, Hockey A, Knight SJL, Davies KE, Richards RI, Sutherland GR (1995) FRAXE and mental retardation. J Med Genet 32:162-169.
61. Murray A, Youings S, Dennis N, Latsky L, Linehan P, McKechnie N, Macpherson J, Pound M, Jacobs P (1996) Population screening at the FRAXA and FRAXE loci: A molecular analysis of boys with learning difficulties and their mothers. Hum Mol Genet 5:727-735.
62. National Society of Genetic Counselors (1995) National Society of Genetic Counselors, Position statement on prenatal and childhood testing for adult-onset disorders. Perspectives Genet Couns 17(3):5.
63. Nolin SL, Lewis FA, Ye LL, Houck GJ, Glicksman AE, Limprasert P, Li SY, Zhong N, Ashley AE, Feingold E, Sherman SL, Brown ST (1996) Familial transmission of the FMR-1 CGG repeat. Am J Hum Genet 59:1252-1261.
64. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel J-L (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1097-1102.
65. Partington MW, Moore DY, Turner GM (1996) Confirmation of early menopause in fragile X carriers. Am J Med Genet 64:370-372.
66. Pieretti M, Zhang F, Fu Y-H, Warren ST, Oostra BA, Caskey CT, Nelson DL (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
67. Reiss AL, Hagerman RJ, Vinegradov S, Abrams M, King RJ (1988) Psychiatric disability in female carriers of the fragile X chromosome. Arch Genet Psychiatr 45:25-30.
68. Reiss AL, Kazazian HH, Krebs CM, McAughan A, Boehm CD, Abrams MT, Nelson DL (1994) Frequency and stability of the fragile X premutation. Hum Mol Genet 3:393-398.
69. Reyniers E, Vits I, De Boulle K, Van Roy B, Van Velzen D, De Graaff E, Verkerk AJMH, Jorens HZU, Darby K, Oostra BA, Willems P (1993) The full mutation in the FMR1 gene of male fragile X patients is absent in their sperm. Nat Genet 4:143-146.
70. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, van Der Hagen C, Delozier-Blanchet C, Croquette M-F, Gilgenkrants S, Jalbert P, Voelckel MA, Oberle I, Mandel JL (1991) Direct diagnosis by DNA analysis of the fragile X syndrome mental retardation. NEJM 325:1673-1681.
71. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malgran H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schwartz C, Mandel JL (1994a) A multicenter study on genotype-phenotype correlation in the fragile X syndrome, using direct diagnosis with the probe STB 12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
72. Rousseau F, Robb LJ, Rouillard P, Der Kaloustian VM (1994b) No mental retardation in a man with 40% abnormal methylation at the FMR-1 locus and transmission of sperm cells as premutation. Hum Mol Genet 3:927-930.
73. Rousseau F, Rouillard P, Khandjian EW, Morgan K (1995) Prevalence of carriers of premutation-size alleles of the FRM1 gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1018.
74. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJA, Stevenson RE (1994) Obstetrical and gynecological complications in fragile X carriers: A multicenter study. Am J Med Genet 51:400-402.
75. Sherman SI, Meadows KL, Ashley AE (1996) Examination of factors that influence the expansion of the fragile X mutation. Am J Med Genet 64:256-260.
76. Siomi H, Choi M, Siomi MC, Nussbaum, Dreyfuss G (1994) Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
77. Smeets HJM, Smits APT, Verheij CE, Theelen JPG, Willemsen R, Vande Burgt I, Hoogeveen AT, Oosterwijk JC, Oostra BA (1995) Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 4:2103-2108.
78. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN (1993) Analysis of the CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
79. Spiridigliozzi GA, Lachiewicz AM, McConkie-Rosell A, Tarleton J (1995) Developmental problems in pre-mutation carriers of the FMR-1 gene: Is this fragile X or not? Platform presentation, 7th International Fragile X Meeting. Tromso, Norway.
80. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (1992) DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400.
81. Tarleton J, Saul RA (1998) Gene Clinics: Fragile X syndrome, www.geneclinics.org.
82. Tarleton JC, Saul RA (1993) Molecular genetic advances in fragile X syndrome. J Pediatr 122:169-185.
83. Taylor AK, Safianda JF, Fall MZ, Quince C, Lange KA, Hull CE, Carpenter I, Staley L, Hagerman RJ (1994) Molecular predicators of cognitive involvement in fragile X females. JAMA 271:507-514.
84. Tiberio G (1994) MZ female twins discordant for X-linked diseases: a review. Acta Genet Med Gemellol 43:207-214.
85. Turner G, Webb T, Wake S, Robinson H (1996) The prevalence of the fragile X syndrome. Am J Med Genet 64:196-197.
86. U.S. Preventive Services Task Force. Chairman Harold C. Sox Jr. (1995) Guide to Clinical Preventive Services, 2nd ed, Appendix A. U.S. Government Printing Office. Stock No. 017001005258.
87. Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B, Vieri F, Scarnato P, Gori F, Sereni A (1999) Premature ovarian failure (POF) and fragile X premutation females: From POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 28:300-303.
88. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, Reuser AJ, Hoogeveen AT, Oostra BA (1993) Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
89. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuho DPA, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen GJ, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
90. Vianna-Morgante AM, Costa SS, Pares AS, Verreschi ITN (1996) FRAXA premutation associated with premature ovarian failure. Am J Med Genet 64:373-375.
91. Vits LM, DeBoulle K, Reyniers E, Handig I, Darby JK, Oostra B, Willems PJ (1994) Apparent regression of the CGG repeat in FMR1 to an allele of normal size. Hum Genet 94:523-526.
92. Wertz D, Fanos JH, Reilly PR (1994) Genetic testing for children and adolescents: Who decides? JAMA 272:875-881.
93. Willemsen R, Mohkamsing S, de Vries BBA, Devys D, van den Ouweland A, Mandel JL, Galjaard H, Oostra B (1995) Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148.
94. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, deHaan A, De Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra B (1997) Rapid antibody testing for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308-311.
95. Wohrle D, Hennig I, Vogel W, Steinbach P (1993) Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4:140-142.
96. Wohrle D, Kotzot D, Hirst MC, Manca A, Korn B, Schmidt A, Barbi G, Rott HD, Poustka A, Dabies KE, Steinbach P (1992) A microdeletion of less than 250 kb, including the proximal part of the FMR-1 gene and the fragile X site, in a male with the clinical phenotype of fragile X syndrome. Am J Hum Genet 51:299-306.
97. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richards RI (1991) Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-1181.
98. Zhong N, Ju W, Pietrofesa J, Wang D, Dobkin C, Brown WT (1996) Fragile X "gray zone" alleles: AGG patterns, expansion risks and associated haplotypes. Am J Med Genet 64:261-265.